Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of plasma P-tau181 with memory decline in non-demented adults
Joseph Therriault, Andréa Lessa Benedet, Tharick A. Pascoal, et al.
Brain Communications (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 538
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
Marta Milà‐Alomà, Nicholas J. Ashton, Mahnaz Shekari, et al.
Nature Medicine (2022)
Open Access | Times Cited: 238
Blood‐based biomarkers for Alzheimer's disease
Antoine Leuzy, Niklas Mattsson, Sebastian Palmqvist, et al.
EMBO Molecular Medicine (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 223
Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease
Joseph Therriault, Stijn Servaes, Cécile Tissot, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 4967-4977
Open Access | Times Cited: 82
Predicting amyloid PET and tau PET stages with plasma biomarkers
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Brain (2023) Vol. 146, Iss. 5, pp. 2029-2044
Open Access | Times Cited: 76
Biomarker-based staging of Alzheimer disease: rationale and clinical applications
Joseph Therriault, Suzanne E. Schindler, Gemma Salvadó, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 4, pp. 232-244
Closed Access | Times Cited: 58
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals
Clifford R. Jack, Heather J. Wiste, Alicia Algeciras‐Schimnich, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 3, pp. 2143-2154
Open Access | Times Cited: 19
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker‐guided diagnostics
Hyemin Jang, Daeun Shin, Heejin Yoo, et al.
Alzheimer s & Dementia (2025)
Open Access | Times Cited: 2
Diagnostic value of serum versus plasma phospho-tau for Alzheimer’s disease
Przemysław R. Kac, Fernándo González‐Ortiz, Joel Simrén, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 49
Developments in scalable strategies for detecting early markers of cognitive decline
Robert Whelan, Florentine Barbey, Márcia R. Cominetti, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
Pia Kivisäkk, Becky C. Carlyle, Thadryan Sweeney, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 38
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022
Dallas P. Veitch, Michael W. Weiner, Melanie J. Miller, et al.
Alzheimer s & Dementia (2023) Vol. 20, Iss. 1, pp. 652-694
Open Access | Times Cited: 37
The Associations of Phosphorylated Tau 181 and Tau 231 Levels in Plasma and Cerebrospinal Fluid with Cognitive Function in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Zhirui Li, Zixuan Fan, Qian Zhang
Journal of Alzheimer s Disease (2024) Vol. 98, Iss. 1, pp. 13-32
Closed Access | Times Cited: 12
Prognostic and Predictive Factors in Early Alzheimer’s Disease: A Systematic Review
Maria João Garcia, Regina Leadley, Janine Ross, et al.
Journal of Alzheimer s Disease Reports (2024) Vol. 8, Iss. 1, pp. 203-240
Open Access | Times Cited: 9
Present and Future of Blood-Based Biomarkers of Alzheimer’s Disease: Beyond the Classics
Marina Mantellatto Grigoli, Lucas Nogueira de Carvalho Pelegrini, Robert Whelan, et al.
Brain Research (2024) Vol. 1830, pp. 148812-148812
Closed Access | Times Cited: 9
Performance of a fully-automated Lumipulse plasma phospho-tau181 assay for Alzheimer’s disease
Edward N. Wilson, Christina B. Young, Javier Ramos Benitez, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 36
Predictive blood biomarkers and brain changes associated with age-related cognitive decline
Tyler S. Saunders, Francesca E Pozzolo, Amanda Heslegrave, et al.
Brain Communications (2023) Vol. 5, Iss. 3
Open Access | Times Cited: 17
Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population‐based study
Yingjin Zhang, Pâmela C.L. Ferreira, Erin Jacobsen, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 4199-4211
Open Access | Times Cited: 7
Associations Between Blood-Based Biomarkers and Cognitive and Functional Trajectories Among Participants of the MEMENTO Cohort
Leslie Grasset, Vincent Bouteloup, Federica Cacciamani, et al.
Neurology (2024) Vol. 102, Iss. 9
Open Access | Times Cited: 5
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer’s Disease
Andrea Pilotto, M Parigi, Giulio Bonzi, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 3, pp. 991-997
Open Access | Times Cited: 22
Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults
Emer R. McGrath, Alexa Beiser, Adrienne O’Donnell, et al.
Journal of Alzheimer s Disease (2022) Vol. 87, Iss. 4, pp. 1517-1526
Closed Access | Times Cited: 21
Diagnostic performance of Alzheimer's disease blood biomarkers in a Brazilian cohort
Wyllians Vendramini Borelli, Pâmela C.L. Ferreira, Wagner S. Brum, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Distinct brain pathologies associated with Alzheimer’s disease biomarker-related phospho-tau 181 and phospho-tau 217 in App knock-in mouse models of amyloid-β amyloidosis
Yu Hirota, Yasufumi Sakakibara, Kyoko Ibaraki, et al.
Brain Communications (2022) Vol. 4, Iss. 6
Open Access | Times Cited: 18
Longitudinal associations of serum biomarkers with early cognitive, amyloid and grey matter changes
Steffi De Meyer, Elena R. Blujdea, Jolien Schaeverbeke, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 936-948
Open Access | Times Cited: 10
Plasma Aβ42/Aβ40 and p-tau181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment
Zhenxu Xiao, Wanqing Wu, Xiaoxi Ma, et al.
Clinical Chemistry (2022) Vol. 68, Iss. 12, pp. 1552-1563
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top